摘要:
The invention provides a rubber composition prepared by mixing, per 100 parts by mass of a rubber component comprising at least 50% by mass of a diene-based rubber, from 20 to 150 parts by mass of a filler, and from 0.05 to 30 parts by mass of a compound A which has a specific guanidine structure and has a functional group reactive with the diene-based rubber. The rubber composition improves both a high elastic modulus and a low tan´. The invention also provides a pneumatic tire using the rubber composition.
摘要:
The invention provides a rubber composition prepared by mixing, per 100 parts by mass of a rubber component comprising at least 50% by mass of a diene-based rubber, from 20 to 150 parts by mass of a filler, and from 0.05 to 30 parts by mass of a compound A which has a specific guanidine structure and has a functional group reactive with the diene-based rubber. The rubber composition improves both a high elastic modulus and a low tanδ. The invention also provides a pneumatic tire using the rubber composition.
摘要:
The invention provides a rubber composition prepared by mixing, per 100 parts by mass of the rubber component comprising at least 50% by mass of a diene-based rubber, from 20 to 150 parts by mass of a filler, and from 0.05 to 30 parts by mass of a compound A which has a specific amidine structure and has a functional group reactive with the diene-based rubber. The rubber composition improves both a high elastic modulus and a low tanδ. The invention also provides a pneumatic tire using the rubber composition.
摘要:
The present invention addresses the problem of providing a block copolymer that has excellent adhesion to a base material and that can impart excellent antithrombogenicity to the base material surface, and providing a medical device comprising the block copolymer. The block copolymer according to the present invention comprises an A block and a B block. The A block is capable of containing intermediate water. The B block is more hydrophobic than the A block. The medical device according to the present invention is obtained by coating a medical device with an antithrombotic coating agent containing the block copolymer.
摘要:
This invention provides a peptide that comprises an amino acid sequence consisting of 14 to 18 amino acid residues represented by Formula (I) and is capable of binding to human IgA:
wherein each X is independently selected from among the following: X 1 represents a Gln residue or a Met residue; X 2 and X 3 each independently represent an arbitrary amino acid residue other than Cys or either or both thereof are deleted; X 4 represents an Arg residue or a Gln residue; X 5 represents a Val residue or a Thr residue; X 6 represents a Phe residue or a Tyr residue; X 7 represents a Ser residue or is null; and X 8 represents a Leu residue, a Thr residue, or is null, provided that, when X 1 represents a Met residue, X 7 represents a Ser residue or is null, and X 8 is null. The invention also provides a method for purifying or analyzing human IgA using such peptide.
摘要翻译:本发明提供一种肽,其包含由式(I)表示的14至18个氨基酸残基并能够结合人IgA的氨基酸序列:€ƒ€€ƒ€ƒ€ƒ€ƒH - (X 1)-VCLSYR-(X 2) - (X 3)-G-(X 4)-P-(X 5)-C-(X 6) - (X 7) - (X 8) (I)(I)(SEQ ID NO:1),其中每个X独立地选自以下各项:X 1表示Gln残基或Met残基; X 2和X 3各自独立地表示除Cys之外的任意氨基酸残基,或者两者之一或两者都被缺失; X 4表示Arg残基或Gln残基; X 5表示Val残基或Thr残基; X 6表示Phe残基或Tyr残基; X 7表示Ser残基或无效; 并且X 8表示Leu残基,Thr残基或为空,条件是当X 1表示Met残基时,X 7表示Ser残基或为空,X 8为空。 本发明还提供了使用这种肽纯化或分析人IgA的方法。